<?xml version="1.0" encoding="UTF-8"?>

<rootTag>
  <Award>
    <AwardTitle>SGER: Biophotonics for Diagnosis of Pancreatic Cancer</AwardTitle>
    <AwardEffectiveDate>07/01/2007</AwardEffectiveDate>
    <AwardExpirationDate>12/31/2008</AwardExpirationDate>
    <AwardAmount>160349</AwardAmount>
    <AwardInstrument>
      <Value>Standard Grant</Value>
    </AwardInstrument>
    <Organization>
      <Code>07020000</Code>
      <Directorate>
        <LongName>Directorate For Engineering</LongName>
      </Directorate>
      <Division>
        <LongName>Div Of Chem, Bioeng, Env, &amp; Transp Sys</LongName>
      </Division>
    </Organization>
    <ProgramOfficer>
      <SignBlockName>Leon Esterowitz</SignBlockName>
    </ProgramOfficer>
    <AbstractNarration>CBET-0733868 Backman Pancreatic cancer (PC) has the worst prognosis of any major cancer, with a five-year survival rate below 5%. The reasons for the lethality of PC relates to its tendency to be&lt;br/&gt;diagnosed at a late stage given that potentially curable stages of disease are often&lt;br/&gt;clinically silent. Survival rate dramatically depends on the stage at which PC is&lt;br/&gt;diagnosed. However, pancreatic cancer is insidious in that the development of symptoms&lt;br/&gt;generally portend unresectable and hence uncurable disease. One of the major hurdles&lt;br/&gt;preventing screening for PC is that essentially any interrogation of the pancreas may lead&lt;br/&gt;to serious complications (~20% complication rate). Thus, finding a pre-screening method in&lt;br/&gt;which patients are risk-stratified would be critical for designing screening strategies.&lt;br/&gt;This project focuses on development of a biophotonics approach (a partial wave spectroscopic microscopic technique), to address this problem.</AbstractNarration>
    <MinAmdLetterDate>05/01/2007</MinAmdLetterDate>
    <MaxAmdLetterDate>06/06/2008</MaxAmdLetterDate>
    <ARRAAmount/>
    <AwardID>0733868</AwardID>
    <Investigator>
      <FirstName>Hemant</FirstName>
      <LastName>Roy</LastName>
      <EmailAddress>h-roy@northwestern.edu</EmailAddress>
      <StartDate>05/01/2007</StartDate>
      <EndDate/>
      <RoleCode>Co-Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>Randall</FirstName>
      <LastName>Brand</LastName>
      <EmailAddress>rbrand@enh.org</EmailAddress>
      <StartDate>05/01/2007</StartDate>
      <EndDate/>
      <RoleCode>Co-Principal Investigator</RoleCode>
    </Investigator>
    <Investigator>
      <FirstName>Vadim</FirstName>
      <LastName>Backman</LastName>
      <EmailAddress>v-backman@northwestern.edu</EmailAddress>
      <StartDate>05/01/2007</StartDate>
      <EndDate/>
      <RoleCode>Principal Investigator</RoleCode>
    </Investigator>
    <Institution>
      <Name>Northwestern University</Name>
      <CityName>Evanston</CityName>
      <ZipCode>602013149</ZipCode>
      <PhoneNumber>8474913003</PhoneNumber>
      <StreetAddress>1801 Maple Ave.</StreetAddress>
      <CountryName>United States</CountryName>
      <StateName>Illinois</StateName>
      <StateCode>IL</StateCode>
    </Institution>
    <FoaInformation>
      <Code>0000099</Code>
      <Name>Other Applications NEC</Name>
    </FoaInformation>
    <ProgramElement>
      <Code>7236</Code>
      <Text>BIOPHOTONICS, IMAGING &amp;SENSING</Text>
    </ProgramElement>
    <ProgramReference>
      <Code>0000</Code>
      <Text>UNASSIGNED</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>005E</Code>
      <Text>Neuro-photonics</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>7237</Code>
      <Text>NANO NON-SOLIC SCI &amp; ENG AWD</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>9237</Code>
      <Text>SMALL GRANTS-EXPLORATORY RSRCH</Text>
    </ProgramReference>
    <ProgramReference>
      <Code>OTHR</Code>
      <Text>OTHER RESEARCH OR EDUCATION</Text>
    </ProgramReference>
  </Award>
</rootTag>
